Vynleads (VYND) Gains from Sales and Divestitures (2020 - 2021)
Vynleads (VYND) reported Gains from Sales and Divestitures of $100000.0 for Q1 2021, little changed on a QoQ basis from $100000.0 in Q4 2020.
Vynleads (VYND) has 2 years of Gains from Sales and Divestitures data on file, last reported at $100000.0 in Q1 2021.
- Quarterly Gains from Sales and Divestitures changed N/A year-over-year to $100000.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $100000.0 (changed N/A YoY) and the FY2020 annual result came in at $100000.0, changed N/A from the prior year.
- Gains from Sales and Divestitures was little changed at $100000.0 in Q1 2021 per VYND's latest filing, from $100000.0 in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $100000.0 in Q4 2020 and bottomed at $100000.0 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Vynleads | - | - | -2,028.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 100,000.00 |
| Mar 31, 2021 | 100,000.00 |
| Dec 31, 2020 | 100,000.00 |
| Dec 31, 2020 | 100,000.00 |